Regen BioPharma Inc logo

RGBP - Regen BioPharma Inc Share Price

$0.003 0.0  21.7%

Last Trade - 25/02/21

Micro Cap
Market Cap £930k
Enterprise Value £2.33m
Revenue £77.6k
Position in Universe th / 6713
Unlock RGBP Revenue
Relative Strength (%)
1m +126.6%
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -53.1%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 30th Sep 2013 2014 2015 2016 2017 2018 2019E 2020E CAGR / Avg
0.000 0.000 0.19 0.10 0.11 0.10
Balance Sheet
FINANCIAL BRIEF: : For the nine months ended 30 June 2019, RegenBioPharma Inc revenues decreased 18% to $82K. Net lossapplicable to common stockholders increased 20% to $4.5M.Revenues reflect a decrease in demand for the Company'sproducts and services due to unfavorable market conditions.Higher net loss reflects Derivative Income (Expense)increase of 85% to $2.4M (expense), Interest expenseattributable to Amortiz increase of 17% to $1.2M (expense).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History


RGBP Revenue Unlock RGBP Revenue

Net Income

RGBP Net Income Unlock RGBP Revenue

Normalised EPS

RGBP Normalised EPS Unlock RGBP Revenue

PE Ratio Range

RGBP PE Ratio Range Unlock RGBP Revenue

Dividend Yield Range

RGBP Dividend Yield Range Unlock RGBP Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
Net Profit
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
RGBP EPS Forecasts Unlock RGBP Revenue
Profile Summary

Regen Biopharma, Inc. is a biotechnology company. The Company is focused on identifying regenerative medicine applications in the stem cell/immunotherapy space and advancing these technologies through pre-clinical and Phase I/II clinical trials. The Company is developing products treating blood disorders using small molecules and gene silencing, treating cancer with immunotherapy, modulating molecular processes in cancer stem cell through its molecular targeting approaches, and repairing damaged bone marrow in patients with aplastic anemia and chemotherapy/radiotherapy treated cancer patients. The Company's products include HemaXellarate I, HemaXellerate II, dCellVax, NR2F6 and Tcellvax. The Company is also identifying small molecules through a screening program that inhibits NR2F6 leading to immune cell activation for oncology applications. The Company is also developing drugs that modulate telomere maintenance.

Last Annual September 30th, 2018
Last Interim June 30th, 2019
Incorporated April 24, 2012
Public Since September 3, 2014
No. of Shareholders: n/a
No. of Employees: n/a
Sector Healthcare
Industry Biotechnology & Medical Research
Exchange Pink Sheets on Nasdaq
Shares in Issue 571,484,406
Free Float (0.0%)
Eligible for
RGBP Share Price Performance
Share Price
Bid - Ask
Low - High
Day's Change
Avg Volume
Open - Close
Range (12m)
Latest News for RGBP
Upcoming Events for RGBP
Frequently Asked Questions for Regen BioPharma Inc
What is the Regen BioPharma Inc share price?

As of 25/02/21, shares in Regen BioPharma Inc are trading at $0.003, giving the company a market capitalisation of £930k. This share price information is delayed by 15 minutes.

How has the Regen BioPharma Inc share price performed this year?

Shares in Regen BioPharma Inc are currently trading at $0.003 and the price has moved by 1.43k% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Regen BioPharma Inc price has moved by 1.12k% over the past year.

What are the analyst and broker recommendations for Regen BioPharma Inc?

There are no analysts currently covering Regen BioPharma Inc.

When will Regen BioPharma Inc next release its financial results?

Regen BioPharma Inc is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2020-06-30
What is the Regen BioPharma Inc dividend yield?

Regen BioPharma Inc does not currently pay a dividend.

Does Regen BioPharma Inc pay a dividend?

Regen BioPharma Inc does not currently pay a dividend.

When does Regen BioPharma Inc next pay dividends?

Regen BioPharma Inc does not currently pay a dividend.

How do I buy Regen BioPharma Inc shares?

To buy shares in Regen BioPharma Inc you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Regen BioPharma Inc?

Shares in Regen BioPharma Inc are currently trading at $0.003, giving the company a market capitalisation of £930k.

Where are Regen BioPharma Inc shares listed? Where are Regen BioPharma Inc shares listed?

Here are the trading details for Regen BioPharma Inc:

Country of listing: United States
Exchange: PNK
Ticker Symbol: RGBP
What kind of share is Regen BioPharma Inc?

We were not able to load our ranking data for Regen BioPharma Inc

Is there a Regen BioPharma Inc share price forecast 2021?

We were not able to load any forecast data for Regen BioPharma Inc.

How can I tell whether the Regen BioPharma Inc share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Regen BioPharma Inc. Over the past six months, the relative strength of its shares against the market has been 0.294k%. At the current price of $0.003, shares in Regen BioPharma Inc are trading at 0.279k% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Regen BioPharma Inc PE Ratio?

We were not able to find PE ratio data for Regen BioPharma Inc.

Who are the key directors of Regen BioPharma Inc?

Regen BioPharma Inc's management team is headed by:

Todd Caven - CFO
Who are the major shareholders of Regen BioPharma Inc?

Here are the top five shareholders of Regen BioPharma Inc based on the size of their shareholding:

Pacific Capital Wealth Advisors, Inc. Investment Advisor
Percentage owned: % (n/a shares)
Similar to RGBP
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.